Advertisement

RRT in Liver Failure

  • Vimal Chadha
  • Bradley A. WaradyEmail author
Chapter

Abstract

A 5-year-old boy was seen in the outpatient clinic for evaluation of yellow discoloration of his eyes and skin for the past 2–3 days. His parents reported that his appetite has decreased over the past 1 week and he had been complaining of generalized abdominal discomfort. On examination, he had scleral and cutaneous icterus. His abdomen was distended, and his liver was palpable 3 cm below the costal margin; it was firm and mildly tender. His blood tests revealed hemoglobin 10.7 g/dL, WBC count 6560/mm3, platelet count 168,000/mm3, sodium 140 mEq/L, potassium 4.1 mEq/L, chloride 105 mEq/L, bicarbonate 23 mEq/L, urea nitrogen 4 mg/dL, creatinine 0.37 mg/dL, calcium 9.5 mg/dL, glucose 93 mg/dL, albumin 4 g/dL, bilirubin 13.1 (conjugated 11.7) mg/dL, AST 4410 U/L, ALT 2858 U/L, GGT 155 U/L, and alkaline phosphatase 435 U/L. Imaging studies (ultrasound and MRCP) confirmed hepatosplenomegaly and showed a thickened gall bladder and a normal caliber common bile duct, in addition to mild to moderate ascites. He was hospitalized for a day and then followed as an outpatient. Tests for viral studies and alpha-1 antitrypsin came back negative.

References

  1. 1.
    Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.CrossRefGoogle Scholar
  2. 2.
    Bansal S, Dhawan A. Acute liver failure. Indian J Pediatr. 2006;73:931–4.CrossRefGoogle Scholar
  3. 3.
    Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr. 2005;40:575–81.CrossRefGoogle Scholar
  4. 4.
    Stadbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care. 2007;13:215–21.CrossRefGoogle Scholar
  5. 5.
    Phua J, Lee KH. Liver support devices. Curr Opin Crit Care. 2008;14:208–15.CrossRefGoogle Scholar
  6. 6.
    Hoste EA, Dhondt A. Clinical review: use of renal replacement therapies in special groups of ICU patients. Crit Care. 2012;16:201.CrossRefGoogle Scholar
  7. 7.
    Deep A, Stewart CE, Dhawan A, et al. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med. 2016;44:1910–9.CrossRefGoogle Scholar
  8. 8.
    Arikan AA, Srivaths P, Himes RH, et al. Hybrid extracorporeal therapies as a bridge to pediatric liver transplantation. Pediatr Crit Care Med. 2018;19(7):e342–9.Google Scholar
  9. 9.
    Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care. 2007;23(2):129–35.CrossRefGoogle Scholar
  10. 10.
    Desjardins P, Du T, Jiang W, et al. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int. 2012;60:690–6.CrossRefGoogle Scholar
  11. 11.
    Lee WM, Stravitz RT, Larson AM. Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55:965–7.CrossRefGoogle Scholar
  12. 12.
    Murphy N, Auzinger G, Bernal W, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2002;39:464–70.CrossRefGoogle Scholar
  13. 13.
    Mohan N, Ragunathan V, Dhaliwal M, et al. Prevalence of acute kidney injury network (AKIN) in pediatric non acetaminophen acute liver failure (pNA-ALF) & addition of AKIN staging to King’s college criteria (Kcc) in pNAALF improves prognostic value. J Clin Exp Hepatol. 2013;3:S17.CrossRefGoogle Scholar
  14. 14.
    Tujios SR, Hynan SL, Vazquez MA, et al. Risk factor and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13(2):352–9.CrossRefGoogle Scholar
  15. 15.
    Symons JM, Chua AN, Somers MJ, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol. 2007;2:732–8.CrossRefGoogle Scholar
  16. 16.
    Squires RH Jr. Acute liver failure in children. Semin Liver Dis. 2008;28:153.CrossRefGoogle Scholar
  17. 17.
    Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.CrossRefGoogle Scholar
  18. 18.
    Davenport A, Will EJ, Davison AM. Early changes in intracranial pressure during hemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant. 1990;5(3):192–8.CrossRefGoogle Scholar
  19. 19.
    Chevret L, Durand P, Lambert J, et al. High-volume hemofiltration in children with acute liver failure. Pediatr Crit Care Med. 2014;15:e300–5.CrossRefGoogle Scholar
  20. 20.
    Sauer IM, Goetz M, Steffen I, et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology. 2004;39:1408–14.CrossRefGoogle Scholar
  21. 21.
    Chawla LS, Georgescu F, Abell B, et al. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis. 2005;3:e51–6.CrossRefGoogle Scholar
  22. 22.
    Rodriguez K, Srivaths PR, Tal L, et al. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One. 2017;12:e0182134.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Missouri–Kansas City School of MedicineKansas CityUSA
  2. 2.Division of Pediatric NephrologyChildren’s Mercy Kansas CityKansas CityUSA

Personalised recommendations